FaSSIF-V3, but not compendial media, appropriately detects differences in the peak and extent of exposure between reference and test formulations of ibuprofen-Reference-Cited by-同舟云学术

FaSSIF-V3, but not compendial media, appropriately detects differences in the peak and extent of exposure between reference and test formulations of ibuprofen

Published:2016-08 Issue: Volume:105 Page:134-140
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Cristofoletti Rodrigo,Dressman Jennifer B.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference51 articles.

1. Risk analysis in bioequivalence and biowaiver decisions;Kubbinga;Biopharm. Drug Dispos.,2013

2. International Conference on Harmonization (ICH), Q9 quality risk management, 2005. (accessed February 25, 2016).

3. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies;Cristofoletti;J. Pharm. Sci.,2013

4. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC;Tsume;Eur. J. Pharm. Sci.,2014

5. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults;Psachoulias;Pharm. Res.,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report;Molecular Pharmaceutics;2024-07-01

2. Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers;European Journal of Pharmaceutics and Biopharmaceutics;2024-06

3. Evaluation and prediction of oral drug absorption and bioequivalence with food-druginteraction;Drug Metabolism and Pharmacokinetics;2023-06

4. Exploring in vitro solubility of lamotrigine in physiologically mimetic conditions to prospect the in vivo dissolution in pediatric population;Biopharmaceutics & Drug Disposition;2023-03-23

5. Lowly-buffered biorelevant dissolution testing is not necessarily biopredictive of human bioequivalence study outcome: Relationship between dissolution and pharmacokinetics;International Journal of Pharmaceutics;2023-01